Caixin Global(@caixin):China is the first country to approve a breakthrough narcolepsy drug from Japan’s Takeda Pharmaceutical, underscoring how Beijing’s regulatory overhaul is prompting global drugmakers to debut new therapies in the country ahead of the U.S. and Europe.

Caixin Global

@caixin

Award-winning journalism from China's most respected newsroom. App:

加入 January 2010

77 正在关注 90.8K 粉丝

Caixin Global@caixin

2026.08.05 11:23

China is the first country to approve a breakthrough narcolepsy drug from Japan’s Takeda Pharmaceutical, underscoring how Beijing’s regulatory overhaul is prompting global drugmakers to debut new therapies in the country ahead of the U.S. and Europe.

显示更多